State Street Corp Innoviva, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Innoviva, Inc. stock. As of the latest transaction made, State Street Corp holds 2,458,670 shares of INVA stock, worth $44.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,458,670

Previous 2,450,634 0.33%

Holding current value

$44.5 Million

Previous $47.3 Million 9.81%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.35 - $20.32 $139,424 - $163,291	8,036 Added 0.33%	2,458,670 $42.7 Million
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $291,653 - $357,914	-17,860 Reduced 0.72%	2,450,634 $47.3 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $539,985 - $614,983	-37,499 Reduced 1.5%	2,468,494 $40.5 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $186,149 - $214,532	-12,785 Reduced 0.51%	2,505,993 $38.2 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $1.85 Million - $2.45 Million	150,465 Added 6.35%	2,518,778 $40.4 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $166,302 - $186,737	-13,444 Reduced 0.56%	2,368,313 $30.8 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $23,315 - $28,084	-2,047 Reduced 0.09%	2,381,757 $30.3 Million
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $1.39 Million - $1.77 Million	129,816 Added 5.76%	2,383,804 $26.8 Million
Q4 2022 Feb 14, 2023	SELL	$11.8 - $13.78 $2.56 Million - $2.99 Million	-216,906 Reduced 8.78%	2,253,988 $29.9 Million
Q3 2022 Nov 15, 2022	BUY	$11.61 - $15.22 $160,055 - $209,822	13,786 Added 0.56%	2,470,894 $28.7 Million
Q2 2022 Aug 15, 2022	BUY	$14.32 - $19.88 $6.38 Million - $8.86 Million	445,546 Added 22.15%	2,457,108 $36.3 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $3.01 Million - $3.96 Million	-195,546 Reduced 8.86%	2,011,562 $38.9 Million
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $264,392 - $311,088	-16,618 Reduced 0.75%	2,207,108 $38.1 Million
Q3 2021 Nov 15, 2021	SELL	$13.06 - $17.24 $2.59 Million - $3.41 Million	-197,971 Reduced 8.17%	2,223,726 $37.2 Million
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $1.03 Million - $1.26 Million	90,014 Added 3.86%	2,421,697 $32.5 Million
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $1.59 Million - $1.85 Million	144,040 Added 6.58%	2,331,683 $27.9 Million
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $364,019 - $486,919	39,016 Added 1.82%	2,187,643 $27.1 Million
Q3 2020 Nov 10, 2020	SELL	$10.33 - $14.49 $1.42 Million - $2 Million	-137,840 Reduced 6.03%	2,148,627 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $952,900 - $1.27 Million	82,933 Added 3.76%	2,286,467 $32 Million
Q1 2020 May 11, 2020	BUY	$8.11 - $15.23 $17.9 Million - $33.6 Million	2,203,534 New	2,203,534 $25.9 Million

Others Institutions Holding INVA

# of Institutions

243

Shares Held

77.7M

Call Options Held

52.8K

Put Options Held

800

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Innoviva, Inc. Transaction History